LNTH (Lantheus Holdings, Inc.) — AI Stock Analysis & Recommendation

Research of August 4, 2026 · Healthcare / In Vitro & In Vivo Diagnostic Substances

TradeFlare's AI research teams rate LNTH a HOLD. The latest price is $100.02.

The research plan

• Entry: $101.11
• Time horizon: weeks

The acquisition news creates uncertainty and limits immediate upside potential.

Why

Despite positive fundamental aspects like strong profitability and financial health, the stock is currently capped by the pending acquisition by Curium, which limits standalone upside. The neutral technical and sentiment scores, coupled with a high-risk assessment, prevent a bullish recommendation. The stock is best held until the acquisition is finalized or further clarity emerges on its standalone prospects.

What could push LNTH higher

• Successful completion of the acquisition by Curium.
• Realization of cost discipline benefits from workforce reduction.
• Strong performance of Lantheus's key products.

Key risks for LNTH

• The acquisition price may not be fully realized due to contingent value rights (CVRs).
• High risk profile due to deep drawdown, volatility, and elevated short interest.
• Product concentration and competitive pressures in the healthcare sector.

What each AI research team found

Fundamental team: Neutral · valuation: fair

Lantheus Holdings presents a neutral fundamental outlook due to the pending acquisition by Curium, which effectively caps the stock's upside at the offer price of $102.50. While the company exhibits strong underlying fundamentals, including exceptional earnings growth, high margins, and robust cash flow, the acquisition narrative dominates the standalone valuation. The current price trading near the offer price,...

• The pending acquisition by Curium for $102.50 per share significantly anchors the stock's valuation, limiting standalone upside and downside.
• Lantheus Holdings demonstrates strong profitability with high gross margins (60.48%) and exceptional earnings growth (76.5% YoY), despite modest revenue growth (1.2% YoY).
• The company exhibits excellent financial health with strong liquidity (Current Ratio: 2.83, Quick Ratio: 2.57) and robust free cash flow generation (TTM $371.7M).

Technical team: Neutral

Lantheus Holdings is currently in a neutral consolidation phase, trading near resistance with bearish short-term technical signals and declining volume. While the long-term trend is bullish, the immediate outlook suggests a potential for a short-term pullback towards the support level at $95.54, given the current bearish momentum and lack of pattern confirmation.

• The stock is in a sideways trend, with short-term moving averages showing a bearish crossover below the MA50, while the long-term MA200 remains bullish.
• Volume is decreasing and below the 20-day moving average, with a recent high-volume down day near resistance suggesting potential distribution.
• All momentum indicators (RSI, MACD, Stochastic) are showing bearish signals and are trending downwards, indicating weakness.

Sentiment team: Neutral

Lantheus Holdings (LNTH) sentiment is currently neutral across news, social media, and professional analyst views. While a significant acquisition by Curium and strong past performance are positive drivers, concerns about the offer valuation, contingent value rights, and a recent analyst downgrade create a balanced outlook. The stock's price is currently at $0.00, which is unusual and likely a placeholder,...

• Lantheus (LNTH) news sentiment is neutral, driven by a significant acquisition agreement with Curium, but tempered by uncertainties surrounding contingent value rights, suspended guidance, and a past FDA setback. (Score: 0.021)
• LNTH sentiment is neutral, driven by a significant acquisition by Curium, though concerns exist regarding the offer price and shareholder fairness. (Score: 0.021)
• Lantheus (LNTH) sentiment is neutral, driven by a significant acquisition deal with Curium and strong recent financial performance, but tempered by a recent analyst downgrade and investor concerns about the acquisition offer's valuation.

Risk team: High

Lantheus Holdings presents a high-risk profile due to significant historical drawdowns, elevated short interest, and substantial company-specific risks including product concentration and manufacturing vulnerabilities. Despite the potential upside from cost discipline signaled by workforce reductions, the confluence of these factors necessitates a cautious approach and a small position size.

• Deep Drawdown & High Volatility: The stock has experienced a significant -59.46% drawdown over the past year and exhibits high annualized volatility (20d: 37.64%, 60d: 38.88%), indicating substantial downside risk and potential for large price swings.
• Elevated Short Interest & Days to Cover: High short interest (>10%) and days to cover (>5) signal significant bearish sentiment, increasing the risk of amplified downside or volatile short squeezes.
• Product Concentration & Competition: Over-reliance on key products exposes LNTH to pricing pressure and generic competition, while the success of new launches and acquisitions remains uncertain.

LNTH at a glance

Market value	$6.5B
Price / earnings	23.7
Revenue growth (year over year)	2.3%
Profit margin	17.7%
Debt / equity	0.43

Every AI call on LNTH since May 11, 2026, and what happened next (5 calls) →

Research of August 4, 2026 · AI-generated analysis for educational purposes, can be wrong, not financial advice.